Error message

Enter key-codes to unlock Personalized Downloads field is required.

"Thanks to new Multiplicom test kits physicians are able to identify all the genetic mutations of a condition at once, and use this information to initiate the right - personalized - treatment.”

Genomeweb - Agilent to Acquire Multiplicom for €68M

NEW YORK (GenomeWeb) – Agilent Technologies announced today that it has agreed to acquire Belgium-based molecular diagnostics developer Multiplicom for €68 million ($70.6 million) in cash.
The deal is expected to close in mid-January. All 90 Multiplicom employees will be offered jobs within Agilent, the company said.
"The acquisition of Multiplicom significantly strengthens our presence in the genomics market," Herman Verrelst, vice president and general manager of Agilent's genomics division, said in a statement. "Multiplicom's products and technology help expand our target-enrichment portfolio and enhance our next-generation sequencing workflow capabilities, providing immediate scale in adjacent markets."
Click here to read the original article on Genomeweb.